Download Zipped Introduced WordPerfect HB0030.ZIP
[Status][Bill Documents][Fiscal Note][Bills Directory]

H.B. 30

             1     

DRUG LAW AMENDMENTS

             2     
2010 GENERAL SESSION

             3     
STATE OF UTAH

             4     
Chief Sponsor: Trisha S. Beck

             5     
Senate Sponsor: Curtis S. Bramble

             6     
             7      LONG TITLE
             8      Committee Note:
             9          The Health and Human Services Interim Committee recommended this bill.
             10      General Description:
             11          This bill modifies Title 58, Chapter 37, Utah Controlled Substances Act, regarding
             12      Schedule IV substances.
             13      Highlighted Provisions:
             14          This bill:
             15          .    adds carisoprodol, which has the brand name of Soma, as a Schedule IV drug.
             16      Monies Appropriated in this Bill:
             17          None
             18      Other Special Clauses:
             19          None
             20      Utah Code Sections Affected:
             21      AMENDS:
             22          58-37-4, as last amended by Laws of Utah 2006, Chapter 8
             23     
             24      Be it enacted by the Legislature of the state of Utah:
             25          Section 1. Section 58-37-4 is amended to read:
             26           58-37-4. Schedules of controlled substances -- Schedules I through V -- Findings
             27      required -- Specific substances included in schedules.


             28          (1) There are established five schedules of controlled substances known as Schedules I,
             29      II, III, IV, and V which shall consist of substances listed in this section.
             30          (2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by
             31      the official name, common or usual name, chemical name, or brand name designated:
             32          (a) Schedule I:
             33          (i) Unless specifically excepted or unless listed in another schedule, any of the
             34      following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
             35      ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
             36      chemical designation:
             37          (A) Acetyl-alpha-methylfentanyl
             38      (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
             39          (B) Acetylmethadol;
             40          (C) Allylprodine;
             41          (D) Alphacetylmethadol, except levo-alphacetylmethadol also known as
             42      levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
             43          (E) Alphameprodine;
             44          (F) Alphamethadol;
             45          (G) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
             46      propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
             47          (H) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
             48      piperidinyl]-N-phenylpropanamide);
             49          (I) Benzethidine;
             50          (J) Betacetylmethadol;
             51          (K) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
             52      piperidinyl]-N-phenylpropanamide);
             53          (L) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
             54      phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
             55          (M) Betameprodine;
             56          (N) Betamethadol;
             57          (O) Betaprodine;
             58          (P) Clonitazene;


             59          (Q) Dextromoramide;
             60          (R) Diampromide;
             61          (S) Diethylthiambutene;
             62          (T) Difenoxin;
             63          (U) Dimenoxadol;
             64          (V) Dimepheptanol;
             65          (W) Dimethylthiambutene;
             66          (X) Dioxaphetyl butyrate;
             67          (Y) Dipipanone;
             68          (Z) Ethylmethylthiambutene;
             69          (AA) Etonitazene;
             70          (BB) Etoxeridine;
             71          (CC) Furethidine;
             72          (DD) Hydroxypethidine;
             73          (EE) Ketobemidone;
             74          (FF) Levomoramide;
             75          (GG) Levophenacylmorphan;
             76          (HH) Morpheridine;
             77          (II) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
             78          (JJ) Noracymethadol;
             79          (KK) Norlevorphanol;
             80          (LL) Normethadone;
             81          (MM) Norpipanone;
             82          (NN) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]
             83      propanamide;
             84          (OO) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
             85          (PP) Phenadoxone;
             86          (QQ) Phenampromide;
             87          (RR) Phenomorphan;
             88          (SS) Phenoperidine;
             89          (TT) Piritramide;


             90          (UU) Proheptazine;
             91          (VV) Properidine;
             92          (WW) Propiram;
             93          (XX) Racemoramide;
             94          (YY) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;
             95          (ZZ) Tilidine;
             96          (AAA) Trimeperidine;
             97          (BBB) 3-methylfentanyl, including the optical and geometric isomers
             98      (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); and
             99          (CCC) 3-methylthiofentanyl
             100      (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide).
             101          (ii) Unless specifically excepted or unless listed in another schedule, any of the
             102      following opium derivatives, their salts, isomers, and salts of isomers when the existence of the
             103      salts, isomers, and salts of isomers is possible within the specific chemical designation:
             104          (A) Acetorphine;
             105          (B) Acetyldihydrocodeine;
             106          (C) Benzylmorphine;
             107          (D) Codeine methylbromide;
             108          (E) Codeine-N-Oxide;
             109          (F) Cyprenorphine;
             110          (G) Desomorphine;
             111          (H) Dihydromorphine;
             112          (I) Drotebanol;
             113          (J) Etorphine (except hydrochloride salt);
             114          (K) Heroin;
             115          (L) Hydromorphinol;
             116          (M) Methyldesorphine;
             117          (N) Methylhydromorphine;
             118          (O) Morphine methylbromide;
             119          (P) Morphine methylsulfonate;
             120          (Q) Morphine-N-Oxide;


             121          (R) Myrophine;
             122          (S) Nicocodeine;
             123          (T) Nicomorphine;
             124          (U) Normorphine;
             125          (V) Pholcodine; and
             126          (W) Thebacon.
             127          (iii) Unless specifically excepted or unless listed in another schedule, any material,
             128      compound, mixture, or preparation which contains any quantity of the following hallucinogenic
             129      substances, or which contains any of their salts, isomers, and salts of isomers when the
             130      existence of the salts, isomers, and salts of isomers is possible within the specific chemical
             131      designation; as used in this Subsection (2)(iii) only, "isomer" includes the optical, position, and
             132      geometric isomers:
             133          (A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;
             134      .-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; .-ET; and AET;
             135          (B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
             136      4-bromo-2,5-dimethoxy-.-methylphenethylamine; 4-bromo-2,5-DMA;
             137          (C) 4-bromo-2,5-dimethoxypenethylamine, some trade or other names:
             138      2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;
             139          (D) 2,5-dimethoxyamphetamine, some trade or other names:
             140      2,5-dimethoxy-.-methylphenethylamine; 2,5-DMA;
             141          (E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
             142          (F) 4-methoxyamphetamine, some trade or other names:
             143      4-methoxy-.-methylphenethylamine; paramethoxyamphetamine, PMA;
             144          (G) 5-methoxy-3,4-methylenedioxyamphetamine;
             145          (H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
             146      4-methyl-2,5-dimethoxy-.-methylphenethylamine; "DOM"; and "STP";
             147          (I) 3,4-methylenedioxy amphetamine;
             148          (J) 3,4-methylenedioxymethamphetamine (MDMA);
             149          (K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
             150      alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
             151          (L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as


             152      N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;
             153          (M) 3,4,5-trimethoxy amphetamine;
             154          (N) Bufotenine, some trade and other names:
             155      3-(.-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,
             156      N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
             157          (O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
             158          (P) Dimethyltryptamine, some trade or other names: DMT;
             159          (Q) Ibogaine, some trade and other names:
             160      7-Ethyl-6,6.,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
             161      [5,4-b] indole; Tabernanthe iboga;
             162          (R) Lysergic acid diethylamide;
             163          (S) Marijuana;
             164          (T) Mescaline;
             165          (U) Parahexyl, some trade or other names:
             166      3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
             167          (V) Peyote, meaning all parts of the plant presently classified botanically as
             168      Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from
             169      any part of such plant, and every compound, manufacture, salts, derivative, mixture, or
             170      preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));
             171          (W) N-ethyl-3-piperidyl benzilate;
             172          (X) N-methyl-3-piperidyl benzilate;
             173          (Y) Psilocybin;
             174          (Z) Psilocyn;
             175          (AA) Tetrahydrocannabinols, synthetic equivalents of the substances contained in the
             176      plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives,
             177      and their isomers with similar chemical structure and pharmacological activity such as the
             178      following: .1 cis or trans tetrahydrocannabinol, and their optical isomers .6 cis or trans
             179      tetrahydrocannabinol, and their optical isomers .3,4 cis or trans tetrahydrocannabinol, and its
             180      optical isomers, and since nomenclature of these substances is not internationally standardized,
             181      compounds of these structures, regardless of numerical designation of atomic positions
             182      covered;


             183          (BB) Ethylamine analog of phencyclidine, some trade or other names:
             184      N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
             185      N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
             186          (CC) Pyrrolidine analog of phencyclidine, some trade or other names:
             187      1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
             188          (DD) Thiophene analog of phencyclidine, some trade or other names:
             189      1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and
             190          (EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
             191          (iv) Unless specifically excepted or unless listed in another schedule, any material
             192      compound, mixture, or preparation which contains any quantity of the following substances
             193      having a depressant effect on the central nervous system, including its salts, isomers, and salts
             194      of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
             195      specific chemical designation:
             196          (A) Mecloqualone; and
             197          (B) Methaqualone.
             198          (v) Any material, compound, mixture, or preparation containing any quantity of the
             199      following substances having a stimulant effect on the central nervous system, including their
             200      salts, isomers, and salts of isomers:
             201          (A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
             202      4,5-dihydro-5-phenyl-2-oxazolamine;
             203          (B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
             204      alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
             205          (C) Fenethylline;
             206          (D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
             207      alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
             208      alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;
             209      methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of
             210      optical isomers;
             211          (E) (.)cis-4-methylaminorex ((.)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
             212          (F) N-ethylamphetamine; and
             213          (G) N,N-dimethylamphetamine, also known as


             214      N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
             215          (vi) Any material, compound, mixture, or preparation which contains any quantity of
             216      the following substances, including their optical isomers, salts, and salts of isomers, subject to
             217      temporary emergency scheduling:
             218          (A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
             219          (B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
             220          (vii) Unless specifically excepted or unless listed in another schedule, any material,
             221      compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate
             222      (gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.
             223          (b) Schedule II:
             224          (i) Unless specifically excepted or unless listed in another schedule, any of the
             225      following substances whether produced directly or indirectly by extraction from substances of
             226      vegetable origin, or independently by means of chemical synthesis, or by a combination of
             227      extraction and chemical synthesis:
             228          (A) Opium and opiate, and any salt, compound, derivative, or preparation of opium or
             229      opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,
             230      and their respective salts, but including:
             231          (I) Raw opium;
             232          (II) Opium extracts;
             233          (III) Opium fluid;
             234          (IV) Powdered opium;
             235          (V) Granulated opium;
             236          (VI) Tincture of opium;
             237          (VII) Codeine;
             238          (VIII) Ethylmorphine;
             239          (IX) Etorphine hydrochloride;
             240          (X) Hydrocodone;
             241          (XI) Hydromorphone;
             242          (XII) Metopon;
             243          (XIII) Morphine;
             244          (XIV) Oxycodone;


             245          (XV) Oxymorphone; and
             246          (XVI) Thebaine;
             247          (B) Any salt, compound, derivative, or preparation which is chemically equivalent or
             248      identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these
             249      substances may not include the isoquinoline alkaloids of opium;
             250          (C) Opium poppy and poppy straw;
             251          (D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and
             252      any salt, compound, derivative, or preparation which is chemically equivalent or identical with
             253      any of these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives,
             254      and salts of isomers and derivatives, whether derived from the coca plant or synthetically
             255      produced, except the substances may not include decocainized coca leaves or extraction of coca
             256      leaves, which extractions do not contain cocaine or ecgonine; and
             257          (E) Concentrate of poppy straw, which means the crude extract of poppy straw in either
             258      liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.
             259          (ii) Unless specifically excepted or unless listed in another schedule, any of the
             260      following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
             261      ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
             262      chemical designation, except dextrorphan and levopropoxyphene:
             263          (A) Alfentanil;
             264          (B) Alphaprodine;
             265          (C) Anileridine;
             266          (D) Bezitramide;
             267          (E) Bulk dextropropoxyphene (nondosage forms);
             268          (F) Carfentanil;
             269          (G) Dihydrocodeine;
             270          (H) Diphenoxylate;
             271          (I) Fentanyl;
             272          (J) Isomethadone;
             273          (K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
             274      levomethadyl acetate, or LAAM;
             275          (L) Levomethorphan;


             276          (M) Levorphanol;
             277          (N) Metazocine;
             278          (O) Methadone;
             279          (P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
             280          (Q) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic
             281      acid;
             282          (R) Pethidine (meperidine);
             283          (S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
             284          (T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
             285          (U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
             286          (V) Phenazocine;
             287          (W) Piminodine;
             288          (X) Racemethorphan;
             289          (Y) Racemorphan;
             290          (Z) Remifentanil; and
             291          (AA) Sufentanil.
             292          (iii) Unless specifically excepted or unless listed in another schedule, any material,
             293      compound, mixture, or preparation which contains any quantity of the following substances
             294      having a stimulant effect on the central nervous system:
             295          (A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
             296          (B) Methamphetamine, its salts, isomers, and salts of its isomers;
             297          (C) Phenmetrazine and its salts; and
             298          (D) Methylphenidate.
             299          (iv) Unless specifically excepted or unless listed in another schedule, any material,
             300      compound, mixture, or preparation which contains any quantity of the following substances
             301      having a depressant effect on the central nervous system, including its salts, isomers, and salts
             302      of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
             303      specific chemical designation:
             304          (A) Amobarbital;
             305          (B) Glutethimide;
             306          (C) Pentobarbital;


             307          (D) Phencyclidine;
             308          (E) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
             309      1-piperidinocyclohexanecarbonitrile (PCC); and
             310          (F) Secobarbital.
             311          (v) (A) Unless specifically excepted or unless listed in another schedule, any material,
             312      compound, mixture, or preparation which contains any quantity of Phenylacetone.
             313          (B) Some of these substances may be known by trade or other names:
             314      phenyl-2-propanone[,]; P2P; benzyl methyl ketone[,]; and methyl benzyl ketone.
             315          (vi) Nabilone, another name for nabilone:
             316      (.)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
             317      6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
             318          (c) Schedule III:
             319          (i) Unless specifically excepted or unless listed in another schedule, any material,
             320      compound, mixture, or preparation which contains any quantity of the following substances
             321      having a stimulant effect on the central nervous system, including its salts, isomers whether
             322      optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers,
             323      and salts of isomers is possible within the specific chemical designation:
             324          (A) Those compounds, mixtures, or preparations in dosage unit form containing any
             325      stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were
             326      listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the
             327      Code of Federal Regulations, and any other drug of the quantitive composition shown in that
             328      list for those drugs or which is the same except that it contains a lesser quantity of controlled
             329      substances;
             330          (B) Benzphetamine;
             331          (C) Chlorphentermine;
             332          (D) Clortermine; and
             333          (E) Phendimetrazine.
             334          (ii) Unless specifically excepted or unless listed in another schedule, any material,
             335      compound, mixture, or preparation which contains any quantity of the following substances
             336      having a depressant effect on the central nervous system:
             337          (A) Any compound, mixture, or preparation containing amobarbital, secobarbital,


             338      pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients
             339      which are not listed in any schedule;
             340          (B) Any suppository dosage form containing amobarbital, secobarbital, or
             341      pentobarbital, or any salt of any of these drugs which is approved by the Food and Drug
             342      Administration for marketing only as a suppository;
             343          (C) Any substance which contains any quantity of a derivative of barbituric acid or any
             344      salt of any of them;
             345          (D) Chlorhexadol;
             346          (E) Buprenorphine;
             347          (F) Any drug product containing gamma hydroxybutyric acid, including its salts,
             348      isomers, and salts of isomers, for which an application is approved under the federal Food,
             349      Drug, and Cosmetic Act, Section 505;
             350          (G) Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine:
             351      . -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;
             352          (H) Lysergic acid;
             353          (I) Lysergic acid amide;
             354          (J) Methyprylon;
             355          (K) Sulfondiethylmethane;
             356          (L) Sulfonethylmethane;
             357          (M) Sulfonmethane; and
             358          (N) Tiletamine and zolazepam or any of their salts, some trade or other names for a
             359      tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:
             360      2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:
             361      4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
             362      flupyrazapon.
             363          (iii) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a
             364      U.S. Food and Drug Administration approved drug product, some other names for dronabinol:
             365      (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or
             366      (-)-delta-9-(trans)-tetrahydrocannabinol.
             367          (iv) Nalorphine.
             368          (v) Unless specifically excepted or unless listed in another schedule, any material,


             369      compound, mixture, or preparation containing limited quantities of any of the following
             370      narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid:
             371          (A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
             372      milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of
             373      opium;
             374          (B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
             375      milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
             376      therapeutic amounts;
             377          (C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
             378      than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline
             379      alkaloid of opium;
             380          (D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
             381      than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             382      recognized therapeutic amounts;
             383          (E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90
             384      milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
             385      therapeutic amounts;
             386          (F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
             387      than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             388      recognized therapeutic amounts;
             389          (G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not
             390      more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             391      recognized therapeutic amounts; and
             392          (H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with
             393      one or more active, non-narcotic ingredients in recognized therapeutic amounts.
             394          (vi) Unless specifically excepted or unless listed in another schedule, anabolic steroids
             395      including any of the following or any isomer, ester, salt, or derivative of the following that
             396      promotes muscle growth:
             397          (A) Boldenone;
             398          (B) Chlorotestosterone (4-chlortestosterone);
             399          (C) Clostebol;


             400          (D) Dehydrochlormethyltestosterone;
             401          (E) Dihydrotestosterone (4-dihydrotestosterone);
             402          (F) Drostanolone;
             403          (G) Ethylestrenol;
             404          (H) Fluoxymesterone;
             405          (I) Formebulone (formebolone);
             406          (J) Mesterolone;
             407          (K) Methandienone;
             408          (L) Methandranone;
             409          (M) Methandriol;
             410          (N) Methandrostenolone;
             411          (O) Methenolone;
             412          (P) Methyltestosterone;
             413          (Q) Mibolerone;
             414          (R) Nandrolone;
             415          (S) Norethandrolone;
             416          (T) Oxandrolone;
             417          (U) Oxymesterone;
             418          (V) Oxymetholone;
             419          (W) Stanolone;
             420          (X) Stanozolol;
             421          (Y) Testolactone;
             422          (Z) Testosterone; and
             423          (AA) Trenbolone.
             424          (vii) Anabolic steroids expressly intended for administration through implants to cattle
             425      or other nonhuman species, and approved by the Secretary of Health and Human Services for
             426      use, may not be classified as a controlled substance.
             427          (d) Schedule IV:
             428          (i) Unless specifically excepted or unless listed in another schedule, any material,
             429      compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not
             430      less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.


             431          (ii) Unless specifically excepted or unless listed in another schedule, any material,
             432      compound, mixture, or preparation which contains any quantity of the following substances,
             433      including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and
             434      salts of isomers is possible within the specific chemical designation:
             435          (A) Alprazolam;
             436          (B) Barbital;
             437          (C) Bromazepam;
             438          (D) Butorphanol;
             439          (E) Camazepam;
             440          (F) Carisoprodol;
             441          [(F)] (G) Chloral betaine;
             442          [(G)] (H) Chloral hydrate;
             443          [(H)] (I) Chlordiazepoxide;
             444          [(I)] (J) Clobazam;
             445          [(J)] (K) Clonazepam;
             446          [(K)] (L) Clorazepate;
             447          [(L)] (M) Clotiazepam;
             448          [(M)] (N) Cloxazolam;
             449          [(N)] (O) Delorazepam;
             450          [(O)] (P) Diazepam;
             451          [(P)] (Q) Dichloralphenazone;
             452          [(Q)] (R) Estazolam;
             453          [(R)] (S) Ethchlorvynol;
             454          [(S)] (T) Ethinamate;
             455          [(T)] (U) Ethyl loflazepate;
             456          [(U)] (V) Fludiazepam;
             457          [(V)] (W) Flunitrazepam;
             458          [(W)] (X) Flurazepam;
             459          [(X)] (Y) Halazepam;
             460          [(Y)] (Z) Haloxazolam;
             461          [(Z)] (AA) Ketazolam;


             462          [(AA)] (BB) Loprazolam;
             463          [(BB)] (CC) Lorazepam;
             464          [(CC)] (DD) Lormetazepam;
             465          [(DD)] (EE) Mebutamate;
             466          [(EE)] (FF) Medazepam;
             467          [(FF)] (GG) Meprobamate;
             468          [(GG)] (HH) Methohexital;
             469          [(HH)] (II) Methylphenobarbital (mephobarbital);
             470          [(II)] (JJ) Midazolam;
             471          [(JJ)] (KK) Nimetazepam;
             472          [(KK)] (LL) Nitrazepam;
             473          [(LL)] (MM) Nordiazepam;
             474          [(MM)] (NN) Oxazepam;
             475          [(NN)] (OO) Oxazolam;
             476          [(OO)] (PP) Paraldehyde;
             477          [(PP)] (QQ) Pentazocine;
             478          [(QQ)] (RR) Petrichloral;
             479          [(RR)] (SS) Phenobarbital;
             480          [(SS)] (TT) Pinazepam;
             481          [(TT)] (UU) Prazepam;
             482          [(UU)] (VV) Quazepam;
             483          [(VV)] (WW) Temazepam;
             484          [(WW)] (XX) Tetrazepam;
             485          [(XX)] (YY) Triazolam;
             486          [(YY)] (ZZ) Zaleplon; and
             487          [(ZZ)] (AAA) Zolpidem.
             488          (iii) Any material, compound, mixture, or preparation of fenfluramine which contains
             489      any quantity of the following substances, including its salts, isomers whether optical, position,
             490      or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of
             491      isomers is possible.
             492          (iv) Unless specifically excepted or unless listed in another schedule, any material,


             493      compound, mixture, or preparation which contains any quantity of the following substances
             494      having a stimulant effect on the central nervous system, including its salts, isomers whether
             495      optical, position, or geometric isomers, and salts of the isomers when the existence of the salts,
             496      isomers, and salts of isomers is possible within the specific chemical designation:
             497          (A) Cathine ((+)-norpseudoephedrine);
             498          (B) Diethylpropion;
             499          (C) Fencamfamine;
             500          (D) Fenproprex;
             501          (E) Mazindol;
             502          (F) Mefenorex;
             503          (G) Modafinil;
             504          (H) Pemoline, including organometallic complexes and chelates thereof;
             505          (I) Phentermine;
             506          (J) Pipradrol;
             507          (K) Sibutramine; and
             508          (L) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
             509          (v) Unless specifically excepted or unless listed in another schedule, any material,
             510      compound, mixture, or preparation which contains any quantity of dextropropoxyphene
             511      (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
             512          (e) Schedule V: Any compound, mixture, or preparation containing any of the
             513      following limited quantities of narcotic drugs, or their salts calculated as the free anhydrous
             514      base or alkaloid, which includes one or more non-narcotic active medicinal ingredients in
             515      sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal
             516      qualities other than those possessed by the narcotic drug alone:
             517          (i) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
             518          (ii) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
             519      grams;
             520          (iii) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100
             521      grams;
             522          (iv) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of
             523      atropine sulfate per dosage unit;


             524          (v) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
             525          (vi) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
             526      atropine sulfate per dosage unit; and
             527          (vii) unless specifically exempted or excluded or unless listed in another schedule, any
             528      material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant
             529      effect on the central nervous system, including its salts, isomers, and salts of isomers.




Legislative Review Note
    as of 9-21-09 6:43 AM


Office of Legislative Research and General Counsel


[Bill Documents][Bills Directory]